KHDRBS1 and glioblastoma: Finally, our in vivo study showed that the combination of KHDRBS1 knockdown, SNORD51 knockdown and ZBED6 overexpression significantly reduced the volume of the xenograft GBM tumor and prolonged the survival time of nude mice.